Regeneron · 1 day ago
Manager, Biostatistics - Oncology
Tarrytown, NY
Full-time
Onsite
Mid, Senior Level
$115K/yr - $187K/yr
2+ years expRegeneron is a biotechnology company focused on developing innovative medicines. The Manager, Biostatistics - Oncology will support Clinical Biostatistics within Global Development, working with cross-functional teams to design and analyze clinical trials and interpret results.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
The incumbent will work with cross-functional teams to articulate drug development questions, assess the feasibility of endpoints and frame statistical approaches to address those questions, design clinical experiments and interventional studies to generate and analyze the resulting data, and work with teams to appropriately interpret the results and make decisions
The incumbent will co-author clinical study protocols, statistical analysis plans, and perform statistical analyses for interim and final reports
The incumbent will also develop and deliver training to non-statistical colleagues, collaborate on development of new infrastructure and processes, and influence the external pharmaceutical industry and regulatory environment through participation in professional associations, conferences, and publications
Interacting with Medical Directors, Clinical Scientists, Regulatory Affairs, Preclinical scientists, Statistical Programming, Data Management, Medical Writing, and others to design and analyze clinical trials
Developing individual protocols and statistical analysis plans and determines appropriate statistical methodology for data analysis
Collaborating with Statistical Programming on the programming of tables, figures and listings to support decision making and for regulatory reporting
Evaluating appropriateness of available software for planned analyses and determines needs for use of novel statistical methodology or tools
Analyzing data and interprets results from clinical trials and of data from non-trial sources to facilitate program-level decision making
Preparing presentations and written reports to effectively communicate results to the project team, management, and regulatory agencies
Co-presents findings to management
Is involved in research activities for innovative statistical methods and applications in clinical trial development as well as providing training to non-statisticians
Qualification
Required
PhD or equivalent degree in statistics/biostatistics with >2 years' experience in the pharmaceutical industry, or MS degree in statistics/biostatistics with >7 years' experience
Knowledge of drug discovery and development and ability to integrate statistical concepts into drug discovery and development strategies
Excellent influence and leadership skills, and a demonstrated ability to collaborate in a cross-functional environment
Must be able to work productively in a fast-paced collaborative environment, with demonstrated critical thinking skills, time management skills, and effective communication skills
Solid knowledge of statistical analysis methodologies, experimental and clinical trial design
Expertise in statistical software such as R or SAS is required
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
10001+ employees
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
Recent News
Pharmaceutical Technology
2026-01-16
2026-01-16
Company data provided by crunchbase